nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adding to the complexity of fetal and neonatal alloimmune thrombocytopenia: Reduced fibrinogen binding in the presence of anti-HPA-1a antibody and hypo-responsive neonatal platelets
|
Refsum, E. |
|
2018 |
162 |
C |
p. 69-76 |
artikel |
2 |
A prospective study of Rivaroxaban for central venous catheter associated upper extremity deep vein thrombosis in cancer patients (Catheter 2)
|
Davies, G.A. |
|
2018 |
162 |
C |
p. 88-92 |
artikel |
3 |
CREM-transgene mice: A step towards understanding thrombogenesis in atrial fibrillation
|
Akoum, Nazem |
|
2018 |
162 |
C |
p. 60-61 |
artikel |
4 |
Current evidence of oral anticoagulant reversal: A systematic review
|
Tornkvist, Max |
|
2018 |
162 |
C |
p. 22-31 |
artikel |
5 |
Diclofenac for reversal of right ventricular dysfunction in acute normotensive pulmonary embolism: A pilot study
|
Jimenez, David |
|
2018 |
162 |
C |
p. 1-6 |
artikel |
6 |
Editorial Board
|
|
|
2018 |
162 |
C |
p. IFC |
artikel |
7 |
Effect of fibrinogen, fibrin, and fibrin degradation products on transendothelial migration of leukocytes
|
Yakovlev, Sergiy |
|
2018 |
162 |
C |
p. 93-100 |
artikel |
8 |
Effects of forced deep breathing on blood flow velocity in the femoral vein: Developing a new physical prophylaxis for deep vein thrombosis in patients with plaster cast immobilization of the lower limb
|
Nakanishi, Keisuke |
|
2018 |
162 |
C |
p. 53-59 |
artikel |
9 |
Exploration of adherence and patient experiences with DOACs one year after switching from vitamin-K antagonists- insights from the switching study
|
Bartoli- Abdou, John K. |
|
2018 |
162 |
C |
p. 62-68 |
artikel |
10 |
Fibrin opens the “gate” for leukocytes in the endothelium
|
Litvinov, Rustem I. |
|
2018 |
162 |
C |
p. 101-103 |
artikel |
11 |
Guiding curriculum development of a national research training program in thrombosis medicine: A needs assessment involving faculty and trainees
|
Skeith, Leslie |
|
2018 |
162 |
C |
p. 79-86 |
artikel |
12 |
HAPPY NEW CAREER!!
|
Versteeg, Henri H. |
|
2018 |
162 |
C |
p. 87 |
artikel |
13 |
IgA anti-β2 glycoprotein I antibodies: Experience from a large center
|
Vlagea, Alexandru |
|
2018 |
162 |
C |
p. 38-43 |
artikel |
14 |
Impact of age, comorbidity, and polypharmacy on the efficacy and safety of edoxaban for the treatment of venous thromboembolism: An analysis of the randomized, double-blind Hokusai-VTE trial
|
Vanassche, Thomas |
|
2018 |
162 |
C |
p. 7-14 |
artikel |
15 |
Increased platelet activation occurs in cystic fibrosis patients and correlates to clinical status
|
Lindberg, Ulrika |
|
2018 |
162 |
C |
p. 32-37 |
artikel |
16 |
Increasing rates of thrombosis in children with congenital heart disease undergoing cardiac surgery
|
Silvey, Michael |
|
2018 |
162 |
C |
p. 15-21 |
artikel |
17 |
Protease-activated receptor-4 (PAR4) variant influences on platelet reactivity induced by PAR4-activating peptide through altered Ca2+ mobilization and ERK phosphorylation in healthy Japanese subjects
|
Morikawa, Yoichiro |
|
2018 |
162 |
C |
p. 44-52 |
artikel |
18 |
Residual pulmonary embolism as a predictor for recurrence after a first unprovoked episode: Results from the REVERSE cohort study
|
Wan, Tony |
|
2018 |
162 |
C |
p. 104-109 |
artikel |
19 |
Residual pulmonary vascular obstruction as predictor of pulmonary embolism recurrence after a first unprovoked episode
|
Karathanos, Christos |
|
2018 |
162 |
C |
p. 77-78 |
artikel |